Utility and outcomes of hydroxocobalamin use in smoke inhalation patients
详细信息    查看全文
文摘
First study comparing treatment with hydroxocobalamin to a control efficacy group in smoke inhalation patients. Treatment with hydroxocobalamin had no increased risk in mortality. Its use is associated with lower pneumonia rates and ICU length of stay, and less ventilator days.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700